Margie L. Traylor

Margie L. Traylor, listed as board member, appears in our data through filings on Augmedix, Inc. shares, published by SEC (Form 4). The record holds 12 filings, for trades running from 26 October 2021 to 2 October 2024.

Every open-market trade on record is a purchase: 6 purchases worth €135k, and no sale. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. Besides market trades, the filings include 2 share grants and 3 option exercises.

In size, the median ticket on the buying side is €4,064. Clusters matter here: 5 out of 6 purchases overlapped with buying by a colleague within 30 days. When several insiders buy within a few weeks of each other, analysts speak of a cluster purchase.

The latest filing, published on 4 October 2024, reports a transaction of €264k in Augmedix, Inc. The last purchase on record was published on 16 June 2023, which is 1,226 days ago. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. Section 16 rules allow two business days to file each Form 4. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.